Unlicensed medicines contracts awarded in 2026
9 unlicensed medicines contracts awarded in 2026 have their own page.
- Trial medicine and placebo for Bristol NHS trust, from MIAA
October 2026 · Bristol NHS Foundation Trust · £152,440
- ProMed Pharma continues Cardiff's EMBED 3.0 formulation work
October 2026 · Cardiff University · £187,587
- LIONNS-D2 trial CDMO for Cardiff University: Simbec-Orion
September 2026 · Cardiff University · £212,473
- DHA tablets for Birmingham MAMS trial, from Strides Pharma
July 2026 · University of Birmingham · £61,740
- Clinigen supplies nitazoxanide tablets to Belfast HSC Trust
July 2026 · Belfast Health and Social Care Trust · £310,000
- Desferrioxamine infusors for Belfast, from Lloyds Clinical
July 2026 · Belfast Health and Social Care Trust · £150,000
- Cytotoxic products for Hillingdon Hospitals, won by Baxter
May 2026 · The Hillingdon Hospitals NHS Foundation Trust · £9.29m
- EMBED 3.0 study manufacturing for Cardiff, by ProMed Pharma
April 2026 · Cardiff University
- LAMDARCT trial capsules for Belfast Trust, from Almac
January 2026 · Belfast Health and Social Care Trust · £494,448